Atlas Trials

129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation

Clinical trial NCT07192016 · RECRUITING

Trial details

NCT number
NCT07192016
Sponsor
Western University, Canada
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease (COPD)
Start date
2026-04-24
Primary completion
2027-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.